# Colchicine in COVID-19: a Pilot Study

> **NCT04375202** · PHASE2 · TERMINATED · sponsor: **University Of Perugia** · enrollment: 227 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Colchicine 1 MG Oral Tablet

## Key facts

- **NCT ID:** NCT04375202
- **Lead sponsor:** University Of Perugia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-04-18
- **Primary completion:** 2021-10-31
- **Final completion:** 2021-10-31
- **Target enrollment:** 227 (ACTUAL)
- **Why stopped:** Insufficient rate of patient accrual and newly available scientific evidence
- **Last updated:** 2022-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04375202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04375202, "Colchicine in COVID-19: a Pilot Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04375202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*